Cost-effectiveness of screening for colorectal cancer with once-only flexible sigmoidoscopy and faecal occult blood test
Eline Aas ()
No 2008:6, HERO Online Working Paper Series from University of Oslo, Health Economics Research Programme
On the basis of a randomized controlled trial we estimate the cost per life-year gained for six different strategies for colorectal cancer screening. Individuals in the age group 50 to 64 years were randomly selected for either flexible sigmoidoscopy or a combination of flexible sigmoidoscopy and a faecal occult blood test. A comprehensive dataset was collected from the trial to estimate costs and gained life-years. There are some indications that screening for colorectal cancer can be cost-effective, but the results are not statistically significant after this short follow-up period.
Keywords: Keywords – screening; cost-effectiveness analysis; colorectal cancer; multinomial logit; probabilistic sensitivity analysis (search for similar items in EconPapers)
JEL-codes: C41 C52 I10 I18 (search for similar items in EconPapers)
Pages: 47 pages
New Economics Papers: this item is included in nep-hea
References: Add references at CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:hhs:oslohe:2008_006
Access Statistics for this paper
More papers in HERO Online Working Paper Series from University of Oslo, Health Economics Research Programme HERO / Department of Health Management and Health Economics P.O. Box 1089 Blindern, N-0317 Oslo, Norway. Contact information at EDIRC.
Bibliographic data for series maintained by Kristi Brinkmann Lenander ().